Comparison of adequate relief with symptom, global, and responder endpoints in linaclotide phase 3 trials in IBS-C

BACKGROUND: Optimal clinical trial endpoints for irritable bowel syndrome with constipation (IBS-C) are uncertain. OBJECTIVE: The objective of this article is to compare adequate relief (AR) to abdominal/bowel symptoms, global endpoints, and FDA and EMA responder criteria; and to use AR as an anchor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:United European Gastroenterol J
Main Authors: Camilleri, Michael, Lembo, Anthony J, Lavins, Bernard J, MacDougall, James E, Carson, Robyn T, Williams, Valerie SL, Nelson, Lauren M, Shiff, Steven J, Currie, Mark G, Kurtz, Caroline B, Johnston, Jeffrey M
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2015
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4315678/
https://ncbi.nlm.nih.gov/pubmed/25653859
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640614555946
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados